Press releases
- STAAR Surgical Reports First Quarter 2024 Results
- STAAR Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser Vision
- STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel
- STAAR Surgical to Report First Quarter Results on May 7, 2024
- STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024
- STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024
- STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses
- STAAR Surgical to Participate in Two Upcoming Investor Conferences
- STAAR Surgical Reports Fourth Quarter and Fiscal Year 2023 Results
More ▼
Key statistics
As of last trade, STAAR Surgical Co (SR3:FRA) traded at 38.83, 51.68% above the 52 week low of 25.60 set on Feb 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 38.83 |
---|---|
High | 38.83 |
Low | 38.83 |
Bid | 38.82 |
Offer | 39.24 |
Previous close | 39.15 |
Average volume | 0.00 |
---|---|
Shares outstanding | 49.13m |
Free float | 48.85m |
P/E (TTM) | 136.33 |
Market cap | 2.07bn USD |
EPS (TTM) | 0.3093 USD |
Data delayed at least 15 minutes, as of May 24 2024 07:03 BST.
More ▼